2011 Annual Report - AASLD

The Liver Meeting ® 2011 (continued)
Educate / Train
• Leon Schiff State-of-the-Art Lecture
Studies on Multidrug Resistance in Cancer Reveal
New Insights into Liver Physiology delivered by
Michael Gottesman, MD, presented data on the
molecular basis of multidrug resistance in cancer,
including hepatomas.
This annual lecture recognizes Dr. Schiff’s work
to elevate the study and practice of hepatology to
the discipline it is today. A restricted fund has been
established to support the lecture in perpetuity and
AASLD gratefully acknowledges the National Genetics
Institute for their generous support of this program.
• Thomas E. Starzl Transplant Surgery
State-of-the-Art Lecture (LiverLearning)
Presented by Allan D. Kirk, MD, PhD, Tolerance and
Memory outlined the changes in protective and
allo-immunity with particular attention focused
on immune memory and discussed how these
concepts are relevant to the management of
transplant recipients.
This annual lecture recognizes the pioneering
work that Dr. Starzl has done to elevate liver
transplantation from an experimental procedure
to one that saves thousands of lives annually. A
restricted fund has been established to support
the lecture in perpetuity and AASLD gratefully
acknowledges the donors to this fund.
• Hyman J. Zimmerman Hepatotoxicity
State-of-the-Art Lecture
Kathleen M. Giacomini, PhD delivered a lecture titled
Genetic Variants in Hepatic Transporters: Role in
Drug Response and Toxicity to provide an overview
of hepatic drug transporters that play a role in drug
response and toxicity.
The annual presentation of this lecture continues
to recognize Dr. Zimmerman’s contributions to the
field by providing valuable insights on liver toxicity
and injury. A restricted fund has been established
to support the lecture in perpetuity and AASLD
gratefully acknowledges Eli Lilly and Company for
their generous support of this program.
• President’s Choice (LiverLearning)
During the President’s Choice lecture Towards
Immunological Equity: A Global Vision, Jaime
Sepulveda, MD, described the important progress in
Hepatitis B vaccination and other vaccines provided
by GAVI Alliance in poor countries and emphasized
the importance of advocating for reaching global
vaccine equity. Dr. Sepulveda has pioneered work
on vaccines, global public health policy, delivery
and education in the developing countries—most
recently with his role in the landmark report on
“Health Professionals for a New Century”.
CME
The American Association for the Study of Liver
Diseases (AASLD) has been resurveyed by the
Accreditation Council for Continuing Medical
Education (ACCME) and awarded accreditation
for four years as a provider of continuing medical
education for physicians.
American Board of
Internal Medicine (ABIM)
Maintenance of Certification (MOC)
AASLD collaborated with ABIM in 2011 to update
the hepatology medical knowledge module.
Internists and subspecialists, certified in or after
1990, renew their certificates through ABIM’s
Maintenance of Certification (MOC) program.
Medical knowledge modules are components
of MOC that provide evidence of a commitment
to lifelong learning and involvement in periodic
self‐assessment to guide continuing learning. This
module became available for use by diplomates in
early January 2012.
16
american association for the study of liver diseases